Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Tens-of-millions of women every year test positive for human papillomavirus (HPV) at
routine cervical screening. We performed a mixed-methods systematic review using a …

Aims Vulvar squamous cell carcinoma (VSCC) can be subdivided by human papillomavirus
(HPV) status into two clinicopathological entities. Studies on the prognostic significance of …

Despite the existence of a safe and effective vaccine, human papillomavirus (HPV) remains
prevalent in the United States, with late adolescence and early adulthood being periods of …

Background Primary human papillomavirus (HPV) cervical screening is due to be
implemented in England within the next 2 years; however, the acceptability of HPV testing as …

Abstract Background High-risk HPV DNA testing has been proposed as a primary tool for
cervical cancer screening (HPV-CCS) as an alternative to the Papanicolaou cytology …

Key content: An organised screening programme has reduced the incidence of cervical
cancer in the UK. Cervical screening aims to detect and treat premalignant, low‐or high …

Objective: We explored patient perspectives after a positive human papillomavirus (HPV)
self-sampling result to describe experiences and information needs for this home-based …

Background Hand-to-genital contact is hypothesised to be a transmission mode of human
papillomavirus (HPV) of the Alphapapillomavirus genus. We compared the relative …

Problem Objective studies that use validated questionnaires are needed to evaluate the
changes in the sexual functions of women diagnosed with human papillomavirus (HPV) …